Suttle DP - Search Results

1

Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.

Bugg BY, Danks MK, Beck WT, Suttle DP. Bugg BY, et al. Among authors: suttle dp. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7654-8. doi: 10.1073/pnas.88.17.7654. Proc Natl Acad Sci U S A. 1991. PMID: 1652758 Free PMC article.

2

Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26.

Danks MK, Schmidt CA, Cirtain MC, Suttle DP, Beck WT. Danks MK, et al. Among authors: suttle dp. Biochemistry. 1988 Nov 29;27(24):8861-9. doi: 10.1021/bi00424a026. Biochemistry. 1988. PMID: 2853972

3

Molecular cloning and nucleotide sequence for the complete coding region of human UMP synthase.

Suttle DP, Bugg BY, Winkler JK, Kanalas JJ. Suttle DP, et al. Proc Natl Acad Sci U S A. 1988 Mar;85(6):1754-8. doi: 10.1073/pnas.85.6.1754. Proc Natl Acad Sci U S A. 1988. PMID: 3279416 Free PMC article.

4

Altered DNA topoisomerase II in multidrug resistance.

Beck WT, Danks MK, Wolverton JS, Granzen B, Chen M, Schmidt CA, Bugg BY, Friche E, Suttle DP. Beck WT, et al. Among authors: suttle dp. Cytotechnology. 1993;11(2):115-9. doi: 10.1007/BF00749000. Cytotechnology. 1993. PMID: 7764055 Review.

5

Single-strand conformational polymorphism analysis of the M(r) 170,000 isozyme of DNA topoisomerase II in human tumor cells.

Danks MK, Warmoth MR, Friche E, Granzen B, Bugg BY, Harker WG, Zwelling LA, Futscher BW, Suttle DP, Beck WT. Danks MK, et al. Among authors: suttle dp. Cancer Res. 1993 Mar 15;53(6):1373-9. Cancer Res. 1993. PMID: 8383009

6

Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA.

Gudkov AV, Zelnick CR, Kazarov AR, Thimmapaya R, Suttle DP, Beck WT, Roninson IB. Gudkov AV, et al. Among authors: suttle dp. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3231-5. doi: 10.1073/pnas.90.8.3231. Proc Natl Acad Sci U S A. 1993. PMID: 8386368 Free PMC article.

7

Resistance of mammalian tumor cells to inhibitors of DNA topoisomerase II.

Beck WT, Danks MK, Wolverton JS, Chen M, Granzen B, Kim R, Suttle DP. Beck WT, et al. Among authors: suttle dp. Adv Pharmacol. 1994;29B:145-69. doi: 10.1016/s1054-3589(08)61136-9. Adv Pharmacol. 1994. PMID: 8996606 Review. No abstract available.

8

Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.

Beck WT, Cirtain MC, Danks MK, Felsted RL, Safa AR, Wolverton JS, Suttle DP, Trent JM. Beck WT, et al. Among authors: suttle dp. Cancer Res. 1987 Oct 15;47(20):5455-60. Cancer Res. 1987. PMID: 2888532

9

Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor.

Wang Q, Zambetti GP, Suttle DP. Wang Q, et al. Among authors: suttle dp. Mol Cell Biol. 1997 Jan;17(1):389-97. doi: 10.1128/MCB.17.1.389. Mol Cell Biol. 1997. PMID: 8972219 Free PMC article.

10

Catalytic inhibition of DNA topoisomerase II by N-benzyladriamycin (AD 288).

Lothstein L, Suttle DP, Roaten JB, Koseki Y, Israel M, Sweatman TW. Lothstein L, et al. Among authors: suttle dp. Biochem Pharmacol. 2000 Dec 1;60(11):1621-8. doi: 10.1016/s0006-2952(00)00472-x. Biochem Pharmacol. 2000. PMID: 11077044

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters